UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours

European journal of cancer (1990), 2011-01, Vol.47 (1), p.8-32

2011

Volltextzugriff (PDF)

The impact of the granulocyte colony-stimulating factor on chemotherapy dose intensity and cancer survival: a systematic review and meta-analysis of randomized controlled trials

Annals of oncology, 2013-10, Vol.24 (10), p.2475-2484

2013

Volltextzugriff (PDF)

Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy

Journal of thrombosis and haemostasis, 2007-03, Vol.5 (3), p.632-634

2007

Volltextzugriff (PDF)

Febrile neutropenia and related complications in breast cancer patients receiving pegfilgrastim primary prophylaxis versus current practice neutropaenia management: Results from an integrated analysis

European journal of cancer (1990), 2009-03, Vol.45 (4), p.608-617

2009

Volltextzugriff (PDF)

3331 Quality of survival (QoS) concept framework to assess the quality of prolonged life in advanced melanoma (MEL): Principles and application related to treatment with nivolumab (NIVO)

European journal of cancer (1990), 2015-09, Vol.51, p.S674-S675

2015

Volltextzugriff (PDF)

The Evolution of Clinical Trials in Oncology: Randomised Controlled Trials to Real World Studies

Annals of oncology, 2014-09, Vol.25, p.iv41

Lyman, G.H.

2014

Volltextzugriff (PDF)

122INTHE EVOLUTION OF CLINICAL TRIALS IN ONCOLOGY: RANDOMISED CONTROLLED TRIALS TO REAL WORLD STUDIES

Annals of oncology, 2014-09, Vol.25 (suppl_4), p.iv41-iv42

Lyman, G.H.

2014

Volltextzugriff (PDF)

PCN59 Economics of Primary Prophylactic G-CSF Use in Preventing Neutropenia in Elderly Breast Cancer Patients Receiving Chemotherapy: Are Short-Term Increase in Costs Necessarily Bad?

Value in health, 2011, Vol.14 (7), p.A444-A444

2011

Volltextzugriff (PDF)

Cost-Effectiveness of Primary Prophylaxis With Pegfilgrastim Vs Lipegfilgrastim To Reduce The Incidence of Febrile Neutropenia In Patients With Early Stage Breast Cancer or Non-Hodgkin Lymphoma

Value in health, 2015-05, Vol.18 (3), p.A204-A204

2015

Volltextzugriff (PDF)

3002 POSTER DISCUSSION Venous Thromboembolism (VTE) in Cancer Patients Receiving Chemotherapy: a Real-world Analysis of VTE Risk and the Impact of VTE on Healthcare Expenditure

European journal of cancer (1990), 2011, Vol.47, p.S222-S222

2011

Volltextzugriff (PDF)

Overall survival and risk of second malignancies with cancer chemotherapy and G-CSF support

Annals of oncology, 2018-09, Vol.29 (9), p.1903-1910

2018

Volltextzugriff (PDF)

The economics of febrile neutropenia: implications for the use of colony-stimulating factors

European journal of cancer (1990), 1998-11, Vol.34 (12), p.1857-1864

1998

Volltextzugriff (PDF)

PCN138 Patterns of Anticoagulant Use in Cancer Patients Receiving Chemotherapy

Value in health, 2012-11, Vol.15 (7), p.A434-A435

2012

Volltextzugriff (PDF)

Personalized cancer supportive care in COVID-19 era

Annals of oncology, 2020-07, Vol.31 (7), p.835-837

2020

Volltextzugriff (PDF)

Cost-Effectiveness Of Prophylaxis Treatment Strategies For Febrile Neutropenia In Recurrent Ovarian Cancer Patients

Value in health, 2013-05, Vol.16 (3), p.A140-A140

2013

Volltextzugriff (PDF)

The effect of filgrastim or pegfilgrastim on survival outcomes of patients with cancer receiving myelosuppressive chemotherapy

Annals of oncology, 2015-07, Vol.26 (7), p.1452-1458

2015

Volltextzugriff (PDF)

53P Incidence of febrile neutropenia (FN), adherence and compliance to granulocyte colony-stimulating factor (G-CSF) on-body injector (OBI) versus other FN prophylaxis in patients receiving myelosuppressive chemotherapy: Subgroup analysis in breast cancer patients

Annals of oncology, 2021-05, Vol.32, p.S43

2021

Volltextzugriff (PDF)

Prevention of venous thromboembolism in hospitalized medical cancer patients: guidance from the SSC of the ISTH

Journal of thrombosis and haemostasis, 2014-10, Vol.12 (10), p.1746-1749

2014

Volltextzugriff (PDF)

EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphomas and solid tumours

European journal of cancer (1990), 2006-10, Vol.42 (15), p.2433-2453

2006

Volltextzugriff (PDF)

Incidental thyroid nodules on CT: evaluation of 2 risk-categorization methods for work-up of nodules

American journal of neuroradiology : AJNR, 2013-09, Vol.34 (9), p.1812-1817

2013

Volltextzugriff (PDF)

An exponential growth in incidence of thyroid cancer: trends and impact of CT imaging

American journal of neuroradiology : AJNR, 2014-04, Vol.35 (4), p.778-783

2014

Volltextzugriff (PDF)

OC-12 D-dimer levels significantly decline in ambulatory cancer patients receiving rivaroxaban compared to placebo: biomarker analysis of the CASSINI trial

Thrombosis research, 2021-04, Vol.200, p.S12

2021

Volltextzugriff (PDF)

Clinical prediction rules for mortality in patients with pulmonary embolism and cancer to guide outpatient management: a meta‐analysis

Journal of thrombosis and haemostasis, 2018-02, Vol.16 (2), p.279-292

2018

Volltextzugriff (PDF)

Supportive care in patients with cancer during the COVID-19 pandemic

ESMO open, 2021-02, Vol.6 (1), p.100038-100038, Article 100038

2021

Volltextzugriff (PDF)

9225 Hodgkin lymphoma treatment with ABVD in the US and the EU: neutropenia occurrence and impaired chemotherapy delivery

European journal of cancer supplements, 2009, Vol.7 (2), p.567-567

2009

Volltextzugriff (PDF)

1 – 25 von 56

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(55)
Mit Volltextzugriff
(49)

Publikationsform

Artikel
(56)

Sprache

Englisch
(56)

Erscheinungsjahr

n.n

Thema

Humans
(28)
Life Sciences & Biomedicine
(25)
Science & Technology
(25)
Oncology
(17)
Biological And Medical Sciences
(15)
Medical Sciences
(14)
Female
(12)
Adult
(9)
Middle Aged
(9)
Aged
(8)
Male
(8)
Filgrastim
(7)
Neoplasms
(7)
Neutropenia
(7)
Risk Factors
(7)
Tumors
(7)
Granulocyte Colony-Stimulating Factor - Therapeutic Use
(6)
Hematology
(6)
Hematology, Oncology And Palliative Medicine
(6)
Neoplasms - Drug Therapy
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours

The impact of the granulocyte colony-stimulating factor on chemotherapy dose intensity and cancer survival: a systematic review and meta-analysis of randomized controlled trials

Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy

Febrile neutropenia and related complications in breast cancer patients receiving pegfilgrastim primary prophylaxis versus current practice neutropaenia management: Results from an integrated analysis

3331 Quality of survival (QoS) concept framework to assess the quality of prolonged life in advanced melanoma (MEL): Principles and application related to treatment with nivolumab (NIVO)

The Evolution of Clinical Trials in Oncology: Randomised Controlled Trials to Real World Studies

122INTHE EVOLUTION OF CLINICAL TRIALS IN ONCOLOGY: RANDOMISED CONTROLLED TRIALS TO REAL WORLD STUDIES

PCN59 Economics of Primary Prophylactic G-CSF Use in Preventing Neutropenia in Elderly Breast Cancer Patients Receiving Chemotherapy: Are Short-Term Increase in Costs Necessarily Bad?

Cost-Effectiveness of Primary Prophylaxis With Pegfilgrastim Vs Lipegfilgrastim To Reduce The Incidence of Febrile Neutropenia In Patients With Early Stage Breast Cancer or Non-Hodgkin Lymphoma

3002 POSTER DISCUSSION Venous Thromboembolism (VTE) in Cancer Patients Receiving Chemotherapy: a Real-world Analysis of VTE Risk and the Impact of VTE on Healthcare Expenditure

Overall survival and risk of second malignancies with cancer chemotherapy and G-CSF support

The economics of febrile neutropenia: implications for the use of colony-stimulating factors

PCN138 Patterns of Anticoagulant Use in Cancer Patients Receiving Chemotherapy

Personalized cancer supportive care in COVID-19 era

Cost-Effectiveness Of Prophylaxis Treatment Strategies For Febrile Neutropenia In Recurrent Ovarian Cancer Patients

The effect of filgrastim or pegfilgrastim on survival outcomes of patients with cancer receiving myelosuppressive chemotherapy

53P Incidence of febrile neutropenia (FN), adherence and compliance to granulocyte colony-stimulating factor (G-CSF) on-body injector (OBI) versus other FN prophylaxis in patients receiving myelosuppressive chemotherapy: Subgroup analysis in breast cancer patients

Prevention of venous thromboembolism in hospitalized medical cancer patients: guidance from the SSC of the ISTH

EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphomas and solid tumours

Incidental thyroid nodules on CT: evaluation of 2 risk-categorization methods for work-up of nodules

An exponential growth in incidence of thyroid cancer: trends and impact of CT imaging

OC-12 D-dimer levels significantly decline in ambulatory cancer patients receiving rivaroxaban compared to placebo: biomarker analysis of the CASSINI trial

Clinical prediction rules for mortality in patients with pulmonary embolism and cancer to guide outpatient management: a meta‐analysis

Supportive care in patients with cancer during the COVID-19 pandemic

9225 Hodgkin lymphoma treatment with ABVD in the US and the EU: neutropenia occurrence and impaired chemotherapy delivery

Suchergebnisse filtern